[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Andrew Dudum, identified as Chief Executive Officer, director and a 10% owner of Hims & Hers Health, Inc. (HIMS), reported a sale of Class A common stock on 08/07/2025. The Form 4 shows a disposition of 660,000 shares reported as a sale (code S) at an average weighted price of $50.582 per share.

The filing itemizes the reporting person’s remaining beneficial holdings held indirectly through multiple trusts. The form shows 2,214,769 shares noted alongside the Dudum Family Heritage Trust, and additional indirect trust holdings listed as 1,194,545, 990,410, 1,286,627, 534,491, 186,723, 190,126, 321,657, 1,584,506 and 829,185 shares. The Form 4 was signed by an attorney-in-fact.

Insights

Financial Analyst

CEO sold 660,000 HIMS shares at an average $50.582; substantial indirect holdings remain across family trusts.

The transaction reported is a sizeable single-day disposition: 660,000 Class A shares at an average weighted price of $50.582. The filing clearly documents significant residual beneficial ownership through multiple trusts, with one entry showing 2,214,769 shares associated with the Dudum Family Heritage Trust and numerous other trust holdings listed by share amounts. From a financial perspective, the sale increases available float but the Form 4 does not state rationale or any change in executive status, so material valuation implications cannot be determined from the filing alone.

Corporate Governance Expert

Insider sale disclosed; reporting person remains CEO, director and a 10% owner with large trust-held positions.

The Form 4 complies with Section 16 reporting by disclosing an executive sale and enumerating indirect holdings held by trustees of multiple family and GRAT vehicles. The filing records both the transaction details (date and average weighted price) and the structure of ongoing indirect ownership. The document does not provide any attestations about trading plans or reasons for the sale, so governance observers can note transparency of reporting but cannot infer intent or changes to governance from this filing alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dudum Andrew

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/07/2025		S		660,000	D	$50.582(1)	2,214,769	I	Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
Class A Common Stock								92,313	D
Class A Common Stock								1,194,545	I	Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
Class A Common Stock								990,410	I	Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
Class A Common Stock								1,286,627	I	Held by Trustee of AD 2021 GRAT dated 11-1-2021
Class A Common Stock								534,491	I	Held by Trustee of AD 2022 GRAT
Class A Common Stock								186,723	I	Held by Trustee of AD 2025 GRAT 3 dated 5-27-2025
Class A Common Stock								190,126	I	Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock								321,657	I	Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
Class A Common Stock								1,584,506	I	Held by Trustee of AD 2023 GRAT dated 9-5-2023
Class A Common Stock								829,185	I	Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $50.25 - $51.125. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did HIMS CEO Andrew Dudum report on Form 4?

The Form 4 reports a sale of 660,000 Class A common shares by Andrew Dudum on 08/07/2025.

At what price were the HIMS shares sold?

The shares were sold at an average weighted price of $50.582 per share, with a reported price range of $50.25 to $51.125 noted in the explanations.

What is Andrew Dudum's relationship to Hims & Hers (HIMS)?

The filing identifies Andrew Dudum as Chief Executive Officer, a director, and a 10% owner of HIMS.

How much beneficial ownership remains after the reported transaction?

The Form 4 lists an entry of 2,214,769 shares associated with the Dudum Family Heritage Trust and multiple additional indirect trust holdings with specific share amounts detailed in the filing.

Who signed the Form 4 reporting the transaction?

The Form 4 was signed by Alexandra Cotter Wilkins acting as attorney-in-fact for the reporting person.